XML 27 R5.htm IDEA: XBRL DOCUMENT v3.20.1
CONDENSED CONSOLIDATED STATEMENTS OF PREFERRED SHARES AND STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
$ in Thousands
Series Seed Preferred Shares
Series A Preferred Shares
Series B Preferred Shares
Common shares
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Total
Balance at beginning of period at Dec. 31, 2018         $ 1,633 $ (54,185)   $ (52,552)
Balance at beginning of period ( in shares) at Dec. 31, 2018       1,832,923        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Equity-based compensation expense         499     499
Vesting of restricted shares (in shares)       99,911        
Unrealized holding gains on marketable securities             $ 25 25
Net loss           (5,200)   (5,200)
Balance at end of period at Mar. 31, 2019         2,132 (59,385) 25 (57,228)
Balance at end of period ( in shares) at Mar. 31, 2019       1,932,834        
Balance at beginning of period at Dec. 31, 2018 $ 8,658 $ 51,320 $ 79,831          
Balance at beginning of period ( in shares) at Dec. 31, 2018 2,045,556 8,411,368 10,553,483          
Balance at end of period at Mar. 31, 2019 $ 8,658 $ 51,320 $ 79,831          
Balance at end of period ( in shares) at Mar. 31, 2019 2,045,556 8,411,368 10,553,483          
Balance at beginning of period at Dec. 31, 2019       $ 3 238,384 (97,513) 44 140,918
Balance at beginning of period ( in shares) at Dec. 31, 2019       30,110,251        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Equity-based compensation expense         2,544     2,544
Vesting of restricted shares (in shares)       84,247        
Issuance of common shares upon stock option exercise         167     $ 167
Issuance of common shares upon stock option exercise (in shares)       35,822       35,822
Issuance of common stock under the Employee Stock Purchase Plan         681     $ 681
Issuance of common stock under the Employee Stock Purchase Plan (in shares)       53,405        
Unrealized holding gains on marketable securities             571 571
Net loss           (16,746)   (16,746)
Balance at end of period at Mar. 31, 2020       $ 3 $ 241,776 $ (114,259) $ 615 $ 128,135
Balance at end of period ( in shares) at Mar. 31, 2020       30,283,725